ZA200205596B - Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents
Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them.Info
- Publication number
- ZA200205596B ZA200205596B ZA200205596A ZA200205596A ZA200205596B ZA 200205596 B ZA200205596 B ZA 200205596B ZA 200205596 A ZA200205596 A ZA 200205596A ZA 200205596 A ZA200205596 A ZA 200205596A ZA 200205596 B ZA200205596 B ZA 200205596B
- Authority
- ZA
- South Africa
- Prior art keywords
- octahydro
- pyrido
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- ONHPOXROAPYCGT-UHFFFAOYSA-N 2,3,4,6,7,8,9,9a-octahydro-1h-pyrido[1,2-a]pyrazine Chemical class C1CNCC2CCCCN21 ONHPOXROAPYCGT-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0109260A FR2827288B1 (fr) | 2001-07-12 | 2001-07-12 | Nouveaux derives d'octahydro-2h-pyrido[1,2-a]pyrazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200205596B true ZA200205596B (en) | 2003-03-27 |
Family
ID=8865405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200205596A ZA200205596B (en) | 2001-07-12 | 2002-07-12 | Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6992085B2 (h) |
| EP (1) | EP1275647B1 (h) |
| JP (1) | JP3950018B2 (h) |
| KR (1) | KR100485020B1 (h) |
| CN (1) | CN1197863C (h) |
| AR (1) | AR036166A1 (h) |
| AT (1) | ATE254124T1 (h) |
| AU (1) | AU2002300094B2 (h) |
| BR (1) | BR0202681A (h) |
| CA (1) | CA2394027C (h) |
| DE (1) | DE60200089T2 (h) |
| DK (1) | DK1275647T3 (h) |
| EA (1) | EA005160B1 (h) |
| ES (1) | ES2210219T3 (h) |
| FR (1) | FR2827288B1 (h) |
| HU (1) | HUP0202282A3 (h) |
| MX (1) | MXPA02006699A (h) |
| NO (1) | NO322966B1 (h) |
| NZ (1) | NZ520120A (h) |
| PL (1) | PL355034A1 (h) |
| PT (1) | PT1275647E (h) |
| SI (1) | SI1275647T1 (h) |
| TR (1) | TR200302001T4 (h) |
| ZA (1) | ZA200205596B (h) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2004089410A1 (ja) * | 2003-04-03 | 2006-07-06 | 協和醗酵工業株式会社 | 神経因性疼痛の予防及び／または治療剤 |
| MY141255A (en) * | 2003-12-11 | 2010-03-31 | Memory Pharm Corp | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs |
| FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| MXPA06015267A (es) * | 2004-06-22 | 2007-03-15 | Pfizer Prod Inc | Antagonistas diazabiciclicos del receptor histamina-3. |
| RU2442775C2 (ru) * | 2005-07-04 | 2012-02-20 | Хай Пойнт Фармасьютикалс, ЛЛС | Антагонисты гистаминовых н3-рецепторов |
| ES2375929T3 (es) * | 2005-07-04 | 2012-03-07 | High Point Pharmaceuticals, Llc | Antagonistas del receptor histamina h3. |
| US7795262B2 (en) * | 2006-03-10 | 2010-09-14 | Neurogen Corporation | Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| KR100871691B1 (ko) | 2006-10-16 | 2008-12-05 | 삼성전자주식회사 | 병렬 비트 테스트 방법 및 그 방법을 사용하는 반도체메모리 장치 |
| JP7015092B2 (ja) | 2016-07-28 | 2022-02-02 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する含窒素縮環化合物 |
| CA3089498A1 (en) | 2018-01-26 | 2019-08-01 | Shionogi & Co., Ltd. | Condensed ring compounds having dopamine d3 receptor antagonistic effect |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3388128A (en) * | 1965-09-03 | 1968-06-11 | Allan R. Day | Substituted 1, 4-diazabicyclo [4. 4. 9] decanes |
| GB8518236D0 (en) * | 1985-07-19 | 1985-08-29 | Beecham Group Plc | Compounds |
| AU5291793A (en) * | 1992-09-24 | 1994-04-12 | National Institutes Of Health | Aralkyl diazabicycloalkane derivatives for cns disorders |
| US6231833B1 (en) * | 1999-08-05 | 2001-05-15 | Pfizer Inc | 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors |
| US5731307A (en) * | 1994-09-30 | 1998-03-24 | Pfizer, Inc. | Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines |
| DE60031686T2 (de) * | 1999-07-19 | 2007-08-30 | Merck Frosst Canada Ltd., Kirkland | Pyrazinone, diese verbindungen enthaltende zusammenstellungen |
-
2001
- 2001-07-12 FR FR0109260A patent/FR2827288B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-05 MX MXPA02006699A patent/MXPA02006699A/es active IP Right Grant
- 2002-07-10 JP JP2002201793A patent/JP3950018B2/ja not_active Expired - Fee Related
- 2002-07-11 EP EP02291745A patent/EP1275647B1/fr not_active Expired - Lifetime
- 2002-07-11 ES ES02291745T patent/ES2210219T3/es not_active Expired - Lifetime
- 2002-07-11 EA EA200200663A patent/EA005160B1/ru not_active IP Right Cessation
- 2002-07-11 DK DK02291745T patent/DK1275647T3/da active
- 2002-07-11 SI SI200230005T patent/SI1275647T1/xx unknown
- 2002-07-11 AT AT02291745T patent/ATE254124T1/de not_active IP Right Cessation
- 2002-07-11 BR BR0202681-3A patent/BR0202681A/pt not_active IP Right Cessation
- 2002-07-11 NO NO20023345A patent/NO322966B1/no not_active IP Right Cessation
- 2002-07-11 TR TR2003/02001T patent/TR200302001T4/xx unknown
- 2002-07-11 PT PT02291745T patent/PT1275647E/pt unknown
- 2002-07-11 DE DE60200089T patent/DE60200089T2/de not_active Expired - Fee Related
- 2002-07-11 NZ NZ520120A patent/NZ520120A/en unknown
- 2002-07-12 AR ARP020102607A patent/AR036166A1/es unknown
- 2002-07-12 CA CA002394027A patent/CA2394027C/fr not_active Expired - Fee Related
- 2002-07-12 PL PL02355034A patent/PL355034A1/xx not_active Application Discontinuation
- 2002-07-12 ZA ZA200205596A patent/ZA200205596B/xx unknown
- 2002-07-12 KR KR10-2002-0040727A patent/KR100485020B1/ko not_active Expired - Fee Related
- 2002-07-12 CN CNB021241481A patent/CN1197863C/zh not_active Expired - Fee Related
- 2002-07-12 AU AU2002300094A patent/AU2002300094B2/en not_active Ceased
- 2002-07-12 US US10/195,019 patent/US6992085B2/en not_active Expired - Fee Related
- 2002-07-12 HU HU0202282A patent/HUP0202282A3/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0401292A3 (en) | Pyrazolo[1,5-a]pyridines, pharmaceutical compositions containing the same and process for preparation thereof | |
| IL164857A (en) | 1-thia-4,8,diaza-spiro[4.5]decan-3-one compounds, process for preparation thereof and pharmaceutical compositions comprising them | |
| HUP0304082A3 (en) | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0401083A3 (en) | 4-amino-6-phenyl-pyrrolo [2,3-d] pyrimidine derivatives, pharmaceutical compositions containing them and process for the preparation of the compounds | |
| ZA200003702B (en) | Beta-carboline compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| IL145013A0 (en) | Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL157940A0 (en) | Drugs containing triazaspiro [5.5] undecane derivatives as the active ingredient | |
| HUP0201122A3 (en) | Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them | |
| IL161431A0 (en) | beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0202624A3 (en) | Pyrazolo[4,3-d]pyrimidine-derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| MXPA03009206A (es) | FORMULACIONES DE 3,7-DIAZABICICLO [3.3.1] COMO COMPUESTOS ANTIARRiTMICOS. | |
| HUP0001961A3 (en) | Substituted dimeric compounds, a process for their preparation and pharmaceutical compositions contaning them | |
| ZA200100864B (en) | Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200205596B (en) | Octahydro-2H-Pyrido[1,2-A]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0402282A3 (en) | Triazolo[1,5a] quinoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU2002300094A1 (en) | New octahydro-2H-pyrido[1,2-alpha]pyrazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| HUP0401829A3 (en) | Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- or 4-heteroarylcyclohexane compounds, process for their preparation and pharmaceutical compositions containing the (1h)-quinoxalin-2-one compounds | |
| ZA200110314B (en) | Bicyclic amino-pyrazinones compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200202030B (en) | Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200202220B (en) | Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| IL158035A0 (en) | 3, 7-diazabicyclo [3.3.1] formulations as antiarrhythmic compounds | |
| HUP0002277A3 (en) | Bicyclic amino-pyrazinone compounds, a process for their preparation and pharmaceutical compositions containing them | |
| ZA200205666B (en) | N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| ZA200203086B (en) | Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them. | |
| HUP0301466A3 (en) | 2-aminoalkyl-thieno [2,3-d] pyrimidines, process for their preparation and pharmaceutical compositions containing them |